Document Detail


An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.
MedLine Citation:
PMID:  16099596     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The role of adjuvant chemoradiotherapy (CRT) in D2-resected gastric-cancer patients has not been defined yet. We investigated the effect of postoperative chemoradiotherapy on the relapse rate and survival rate of patients with D2-resected gastric cancer. METHODS AND MATERIALS: From August 1995 to April 2001, 544 patients received postoperative CRT after curative D2 resection. During the same period of time, 446 patients received surgery without further adjuvant treatment. The adjuvant CRT consisted of 400 mg/m2 of fluorouracil plus 20 mg/m2 of leucovorin for 5 days, followed by 4,500 cGy of radiotherapy for 5 weeks, with fluorouracil and leucovorin on the first 4 and the last 3 days of radiotherapy. Two 5-day cycles of fluorouracil and leucovorin were given 4 weeks after the completion of radiotherapy. RESULTS: The median duration of overall survival was significantly longer in the CRT group than in the comparison group (95.3 months vs. 62.6 months), which corresponds to a hazard ratio for death of 0.80 (p = 0.0200) or a reduction of 20% in the risk of death in the CRT group. The 5-year survival rates were consistently longer in the CRT group at Stages II, IIIA, IIIB, and IV than those in the comparison group. The CRT was associated with increases in the median duration of relapse-free survival (75.6 months vs. 52.7 months; hazard ratio for relapse, 0.80, p = 0.0160). CONCLUSION: Our results highly suggest that the postoperative chemoradiotherapy in D2-resected gastric-cancer patients can prolong survival and decrease recurrence.
Authors:
Sung Kim; Do Hoon Lim; Jeeyun Lee; Won Ki Kang; John S MacDonald; Chan Hyung Park; Se Hoon Park; Se-Hoon Lee; Kihyun Kim; Joon Oh Park; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Tae Sung Sohn; Jae Hyung Noh; Jin Seok Heo; Yong Il Kim; Chul Keun Park; Keunchil Park
Related Documents :
7640466 - Preoperative intraperitoneal chemotherapy for gastric cancer, with special reference to...
6424926 - Postoperative adjuvant chemotherapy for gastric carcinoma. analysis of data on 1805 pat...
20610246 - Long-term oncologic outcomes from laparoscopic gastrectomy for gastric cancer: a single...
11574636 - A case of bone metastasis from gastric carcinoma after a nine-year disease-free interval.
6548166 - Advanced gastric cancer: experience in scotland using 5-fluorouracil, adriamycin and mi...
19828776 - Equilibrium vitrification of mouse embryos.
Publication Detail:
Type:  Journal Article     Date:  2005-08-15
Journal Detail:
Title:  International journal of radiation oncology, biology, physics     Volume:  63     ISSN:  0360-3016     ISO Abbreviation:  Int. J. Radiat. Oncol. Biol. Phys.     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-11-21     Completed Date:  2006-01-09     Revised Date:  2006-08-24    
Medline Journal Info:
Nlm Unique ID:  7603616     Medline TA:  Int J Radiat Oncol Biol Phys     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1279-85     Citation Subset:  IM    
Affiliation:
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Kangnam-gu, Seoul, South Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenocarcinoma / drug therapy*,  mortality,  radiotherapy*,  surgery
Adult
Aged
Antimetabolites, Antineoplastic / therapeutic use
Chemotherapy, Adjuvant
Female
Fluorouracil / therapeutic use
Gastrectomy / methods
Humans
Leucovorin / therapeutic use
Male
Middle Aged
Neoplasm Recurrence, Local / mortality
Prospective Studies
Radiotherapy Dosage
Radiotherapy, Adjuvant
Stomach Neoplasms / drug therapy*,  mortality,  radiotherapy*,  surgery
Survival Rate
Chemical
Reg. No./Substance:
0/Antimetabolites, Antineoplastic; 51-21-8/Fluorouracil; 58-05-9/Leucovorin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Childhood friends who smoke: do they influence adolescents to make smoking transitions?
Next Document:  Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (Cox-2) expression in the irradiated colorectu...